BlackRock, Inc. 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-18 12:10 pm Sale | 2025-06-30 | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 203,017 1.600% | -632,183 (-75.69%) | Filing |